Type 1 Diabetes
2 competing products in clinical development for Type 1 Diabetes.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Insulin Efsitora Alfa + Insulin Degludec | Eli Lilly | Phase 3 | Completed | 40 |
| Rapamycin + Mycophenolate Mofetil + Tacrolimus + Steroids | Astellas Pharma | Phase 2 | Completed | 35 |